Top-quality Recombinant Mouse α-synuclein/snca Protein Don't Wait [gk2Fpxet]

Top-quality Recombinant Mouse α-synuclein/snca Protein Don't Wait [gk2Fpxet]

Discover the precision and purity of our Top-quality Recombinant Mouse α-synuclein/snca Protein Don't Wait [gk2Fpxet], a critical component for research into neurodegenerative disorders. This protein, derived from E. coli, offers unparalleled quality and reliability for your scientific studies. With a calculated molecular weight of 14.5 kDa and observed molecular weight of 17 kDa, it provides accurate data for your experiments.

• High purity > 95% as determined by reducing SDS-PAGE.
• Low endotoxin < 1.0 EU per μg of the protein.

Product Properties and Specifications

Our Top-quality Recombinant Mouse α-synuclein/snca Protein Don't Wait [gk2Fpxet] is designed for researchers seeking a reliable and high-quality source for their studies. With a sequence of Met1-Ala140 and an accession number of O55042, this protein offers precise data for analysis. It is important to note that the protein is not validated for activity, but its purity and quality are guaranteed.

• Expression Host: E. coli
• Sequence: Met1-Ala140

The product is lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4, ensuring stability and ease of use.

Practical Uses and Benefits

The Top-quality Recombinant Mouse α-synuclein/snca Protein Don't Wait [gk2Fpxet] is an essential tool for researchers investigating Parkinson's Disease and other neurodegenerative disorders. Its high purity and specific sequence make it ideal for various applications, including in vitro studies, cell culture, and diagnostic tests. The protein's stability and ease of reconstitution make it a valuable asset for your laboratory. By using our Top-quality Recombinant Mouse α-synuclein/snca Protein Don't Wait [gk2Fpxet], you can expect accurate and reliable results for your research.

• Accurate and reliable for neurodegenerative research.
• High purity and specific sequence for precise data.

This product is ideal for researchers, medical professionals, and pharmaceutical companies involved in neuroscience and neurology studies.